Jupiter Asset Management Ltd. Purchases 36,086 Shares of Alignment Healthcare, Inc. $ALHC

Jupiter Asset Management Ltd. grew its position in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 20.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 210,170 shares of the company’s stock after purchasing an additional 36,086 shares during the period. Jupiter Asset Management Ltd.’s holdings in Alignment Healthcare were worth $3,667,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Royal Bank of Canada grew its position in Alignment Healthcare by 92.6% in the 1st quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock worth $1,720,000 after purchasing an additional 44,413 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Alignment Healthcare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after buying an additional 2,594 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Alignment Healthcare by 79.1% in the first quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock valued at $18,112,000 after acquiring an additional 429,703 shares in the last quarter. Woodline Partners LP purchased a new stake in shares of Alignment Healthcare during the first quarter valued at approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Alignment Healthcare by 16.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock valued at $5,729,000 after acquiring an additional 44,452 shares during the last quarter. 86.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have weighed in on ALHC. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. The Goldman Sachs Group reissued a “buy” rating and issued a $22.00 price target on shares of Alignment Healthcare in a report on Monday, November 3rd. Piper Sandler increased their price target on shares of Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research report on Tuesday, January 6th. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Barclays boosted their target price on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $23.32.

Insider Transactions at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 282,070 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80. Following the sale, the president owned 1,385,167 shares of the company’s stock, valued at $25,958,029.58. The trade was a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Robert L. Scavo sold 69,541 shares of the company’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the sale, the insider owned 503,014 shares in the company, valued at $9,426,482.36. The trade was a 12.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 2,150,938 shares of company stock worth $42,274,570 over the last quarter. Corporate insiders own 7.00% of the company’s stock.

Alignment Healthcare Trading Down 1.2%

Shares of Alignment Healthcare stock opened at $20.60 on Friday. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The stock’s 50-day simple moving average is $21.03 and its 200 day simple moving average is $18.35. The stock has a market capitalization of $4.12 billion, a P/E ratio of -171.67, a P/E/G ratio of 5.25 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.